AIM ImmunoTech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AIM ImmunoTech and other ETFs, options, and stocks.

About AIM

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. 

CEO
Thomas Kenwood Equels
CEOThomas Kenwood Equels
Employees
23
Employees23
Headquarters
Ocala, Florida
HeadquartersOcala, Florida
Founded
1966
Founded1966
Employees
23
Employees23

AIM Key Statistics

Market cap
2.97M
Market cap2.97M
Price-Earnings ratio
-0.04
Price-Earnings ratio-0.04
Dividend yield
Dividend yield
Average volume
157.23K
Average volume157.23K
High today
$0.7596
High today$0.7596
Low today
$0.6901
Low today$0.6901
Open price
$0.7314
Open price$0.7314
Volume
76.95K
Volume76.95K
52 Week high
$35.96
52 Week high$35.96
52 Week low
$0.6141
52 Week low$0.6141

Stock Snapshot

The current AIM ImmunoTech(AIM) stock price is $0.69, with a market capitalization of 2.97M. The stock trades at a price-to-earnings (P/E) ratio of -0.04.

As of 2026-03-18, AIM ImmunoTech(AIM) stock has fluctuated between $0.69 and $0.76. The current price stands at $0.69, placing the stock +0.0% above today's low and -9.1% off the high.

AIM ImmunoTech(AIM) shares are trading with a volume of 76.95K, against a daily average of 157.23K.

During the past year, AIM ImmunoTech(AIM) stock moved between $0.61 at its lowest and $35.96 at its peak.

During the past year, AIM ImmunoTech(AIM) stock moved between $0.61 at its lowest and $35.96 at its peak.

People also own

Based on the portfolios of people who own AIM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.